Carotid Intima-media Thickness as Cardiovascular Mortality Predictor in Peritoneal Dialysis Patients
NCT ID: NCT02938767
Last Updated: 2016-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
57 participants
OBSERVATIONAL
2012-01-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcome and Risk Factors For Mortality in Peritoneal Dialysis Patients: 20 Years Experience in a Single Turkish Center
NCT02922270
Blood Purification Therapy With Dual-cannula in Jugular-femoral Venous
NCT05510713
Myocardial Stunning During Hemodialysis: Role of Dialyste Calcium Concentration
NCT02545426
Coronary Revascularization in Patients With Dialysis in China
NCT04953819
Urgent-start Peritoneal Dialysis in ESRD Patients:A Multi-center Study
NCT02946528
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
peritoneal dialysis patients
37 peritoneal dialysis patients followed at the Istanbul Medical Faculty from October 1994 to October 2011
No interventions assigned to this group
renal transplant recipients
20 renal transplant recipients followed at the Istanbul Medical Faculty from October 1994 to October 2011 setted as the control group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Kidney transplant recipients whose followed up at least six months from October 1994 to October 2011 (for control group)
Exclusion Criteria
* valvular heart disease,
* any prior coronary intervention and congestive heart failure
* Patients whose left anterior descending coronary artery (LAD) could not be visualized adequately by Doppler echocardiography were also excluded.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasar Caliskan
MD Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yasar Caliskan, MD
Role: PRINCIPAL_INVESTIGATOR
Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3221
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.